EKF Diagnostics Holdings plc (EKF) - Financial and Strategic SWOT Analysis Review

GlobalData
February 3, 2015
56 Pages - GLDATA32764
$300.00

EKF Diagnostics Holdings plc (EKF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

EKF Diagnostics Holdings plc (EKF Diagnostics) is a medical device company. It designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comprises HbA1c analyzers, hemoglobin analyzers, glucose analyzers, lactate analyzers, rapid and sepsis testing kits, reagents, and biomarkers. These products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. It offers these products in more than 100 countries throughout the world through subsidiaries, and distributors under brands such as Quo-Lab, HemataStat, DiaSpect, STAT-Site, UltraCrit, Lactate Scout+, QuPID, True 20, QuStick, and LiquiColor among others. The company operates manufacturing facilities in Russia, Poland, Germany, the UK, Ireland, and the US. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

The company aims to explore the opportunities of its proprietary PointMan DNA enrichment technology for the detection of ultra-low level mutations thereby to advance its application in cancer diagnosis. To this end, EKF Diagnostics collaborated with ANGLE plc to investigate the combination of ANGLE’s Parsortix circulating tumor cell (CTC) harvesting platform with its PointMan DNA enrichment technology as a liquid biopsy.

EKF Diagnostics Holdings plc Key Recent Developments

Jan 28, 2015: EKF Diagnostics provides trading update for the year ended 31 December 2014
Jan 23, 2015: EKF collaborates with ANGLE to investigate the combination of Parsortix circulating tumour cell harvesting platform with PointMan DNA enrichment technology
Jan 23, 2015: PointMan collaboration with ANGLE
Jan 16, 2015: Diaspect Tm A Robust Hand-Held Analyzer Delivering Immediate Hemoglobin Results At ARAB Health 2015
Nov 19, 2013: EKF Diagnostics Acute kidney Injury marker collaboration with Carclo Plc.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
EKF Diagnostics Holdings plc - Key Facts 6
EKF Diagnostics Holdings plc - Key Employees 7
EKF Diagnostics Holdings plc - Key Employee Biographies 8
EKF Diagnostics Holdings plc - Key Operational Employees 9
EKF Diagnostics Holdings plc - Major Products and Services 10
EKF Diagnostics Holdings plc - Medical Equipment Pipeline Products Data 12
EKF Diagnostics Holdings plc Pipeline Products by Equipment Type 12
EKF Diagnostics Holdings plc Pipeline Products by Development Stage 14
EKF Diagnostics Holdings plc - History 16
EKF Diagnostics Holdings plc - Company Statement 18
EKF Diagnostics Holdings plc - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 21
EKF Diagnostics Holdings plc - Business Description 21
EKF Diagnostics Holdings plc - Corporate Strategy 22
EKF Diagnostics Holdings plc - SWOT Analysis 23
SWOT Analysis - Overview 23
EKF Diagnostics Holdings plc - Strengths 23
Strength - Growth through Acquisitions 23
Strength - Strong Product Line: Point-of-Care Diagnostics 23
Strength - Collaborations and Partnerships 23
EKF Diagnostics Holdings plc - Weaknesses 24
Weakness - Dependence on Distributors 24
EKF Diagnostics Holdings plc - Opportunities 25
Opportunity - Positive Outlook: Asia 25
Opportunity - PointMan DNA Enrichment Test Kit: Oncology Applications 25
Opportunity - Growing IVD Market 25
EKF Diagnostics Holdings plc - Threats 26
Threat - Intense Competition 26
Threat - Technology Obsolescence 26
Threat - Foreign Exchange Currency Risk 26
EKF Diagnostics Holdings plc - Key Competitors 27
Section 3 – Company Financial Ratios 28
Financial Ratios - Capital Market Ratios 28
Financial Ratios - Annual Ratios 29
Performance Chart 30
Financial Performance 30
Financial Ratios - Interim Ratios 31
Financial Ratios - Ratio Charts 32
Section 4 – Company’s Lifesciences Financial Deals and Alliances 33
EKF Diagnostics Holdings plc, Medical Equipment, Deals By Year, 2009 to YTD 2015 33
EKF Diagnostics Holdings plc, Medical Equipment, Deals By Type, 2009 to YTD 2015 34
EKF Diagnostics Holdings plc, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 35
EKF Diagnostics Holdings plc, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 36
EKF Diagnostics Holdings plc, Recent Deals Summary 37
Section 5 – Company’s Recent Developments 38
Jan 28, 2015: EKF Diagnostics provides trading update for the year ended 31 December 2014 38
Jan 23, 2015: EKF collaborates with ANGLE to investigate the combination of Parsortix circulating tumour cell harvesting platform with PointMan DNA enrichment technology 40
Jan 23, 2015: PointMan collaboration with ANGLE 41
Jan 16, 2015: Diaspect Tm A Robust Hand-Held Analyzer Delivering Immediate Hemoglobin Results At ARAB Health 2015 42
Oct 27, 2014: EKF Diagnostics To Presented At ASN 2014 In Philadelphia 43
Oct 14, 2014: EKF To Attend CMEF 2014 44
Sep 23, 2014: US Research Collaboration To Develop Blood Tests For Cancer Patients 45
Sep 15, 2014: EKF Diagnostics Half Yearly Report 46
Aug 15, 2014: EKF Diagnostics Holdings anounces Director appointments 50
Jul 23, 2014: EKF Diagnostics Growing Product Portfolio Highlighted at AACC 2014 51
Section 6 – Appendix 52
Methodology 52
Ratio Definitions 52
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables

EKF Diagnostics Holdings plc, Key Facts 6
EKF Diagnostics Holdings plc, Key Employees 7
EKF Diagnostics Holdings plc, Key Employee Biographies 8
EKF Diagnostics Holdings plc, Key Operational Employees 9
EKF Diagnostics Holdings plc, Major Products and Services 10
EKF Diagnostics Holdings plc Number of Pipeline Products by Equipment Type 12
EKF Diagnostics Holdings plc Pipeline Products by Equipment Type 13
EKF Diagnostics Holdings plc Number of Pipeline Products by Development Stage 14
EKF Diagnostics Holdings plc Pipeline Products by Development Stage 15
EKF Diagnostics Holdings plc, History 16
EKF Diagnostics Holdings plc, Other Locations 19
EKF Diagnostics Holdings plc, Subsidiaries 19
EKF Diagnostics Holdings plc, Key Competitors 27
EKF Diagnostics Holdings plc, Ratios based on current share price 28
EKF Diagnostics Holdings plc, Annual Ratios 29
EKF Diagnostics Holdings plc, Interim Ratios 31
EKF Diagnostics Holdings plc, Medical Equipment, Deals By Year, 2009 to YTD 2015 33
EKF Diagnostics Holdings plc, Medical Equipment, Deals By Type, 2009 to YTD 2015 34
EKF Diagnostics Holdings plc, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 35
EKF Diagnostics Holdings plc, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 36
EKF Diagnostics Holdings plc, Recent Deals Summary 37
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55

List of Figures

EKF Diagnostics Holdings plc Pipeline Products by Equipment Type 12
EKF Diagnostics Holdings plc Pipeline Products by Development Stage 14
EKF Diagnostics Holdings plc, Performance Chart (2009 - 2013) 30
EKF Diagnostics Holdings plc, Ratio Charts 32
EKF Diagnostics Holdings plc, Medical Equipment, Deals By Year, 2009 to YTD 2015 33
EKF Diagnostics Holdings plc, Medical Equipment, Deals by Type, 2009 to YTD 2015 34
EKF Diagnostics Holdings plc, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 35
EKF Diagnostics Holdings plc, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 36

$300.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax